DRUG DEVELOPMENT The number of new chemical entities (NCEs) gaining market approval has decreased over the last decade down to 20 per year. The estimated average of new NCEs…

1. OVERALL SYMPOSIUM OBJECTIVES  Name major pieces of legislation impacting research as well as be able to predict how the changes may impact their organizations and be…

1. There’s no need to be tight-lipped: Making the case for pharmaceutical brands to interact on Facebook Prepared by: Stacy Lukasavitz Social Media Strategist 7.12.10 2.…

Slide 1Safety Workshop: Part I Clinical Trial Safety and Safety Monitoring August 18, 2010 Albert Yoyin, M.D. DAIDS Regulatory Support Center (RSC) August 18, 2010 Albert…

Slide 1Avalere Health LLC | The intersection of business strategy and public policy Medicare Reimbursement: Translating Theory into Practice Medicare Congress Pre-Conference…

Slide 1Ethanol Methadone Opiates Phencyclidine II Propoxyphene Salicylate Tricyclic Antidepressants BIOELECTRONICS AND SAFETY/SECURITY Common aim of much biological/medical…

Slide 1What will be covered Background of B Braun Medical Inc. USA Calibration Program FDA Calibration Requirements Going Paperless decision and journey B Braun Medical Inc.,…

Slide 1API Conference- March 2010- Beijing 1 Requirements for the Quality of API from FDA Perspective Brenda Uratani, Ph.D. FDA Assistant Country Director, China Slide 2…

Slide 1http://www.bf-technologies.com 1 Copyright © 2007 BF Technologies, Inc. All Rights Reserved. Telemedicine Technology Summit October 30, 2007 UC Davis Medical Center…

1. What You Want to Know About Generic Drugs Generic Drugs:Safe. Effective.FDA-Approved. 2. What do you want to know aboutALL the medicines you use…. brand-name and generic?…